The microbiome company—Unlocking Nature's full potential

Unculturable microbes • probiotics • disruptive technology platform

Culture and screen up to 30 million strains in a single day

BIOMILLENIA develops microbial strains and discovers new strains with desired properties from previously unculturable microbiomes.

Our disruptive development platform, based on licensed technology that was developed by Harvard University, the BROAD Institute and ESPCI Paris, uniquely combines single-cell culture and advanced assay development with microfluidics-based ultrahigh-throughput screening.

BIOMILLENIA revolutionises the development of non-GMO strains and microbial products based on this unprecedented throughput in culture and analysis of microbial strains as is desired for e.g. the food market. We “Unlock Nature’s Potential” with novel microbes and natural ingredients for better living.

  • Services

    Get access to Biomillenia’s disruptive technology platform in our services department. Our customers obtain improved R&D and product development capabilities by getting better results at higher speed and lower costs.

    Outsource your screening and development activities today to improve your microbial strains or enzymes in a fee-for-service project.

  • Partnering

    We jointly develop novel microbial products and strains to increase our partner’s competitiveness and profitability by product innovation. Products, formerly difficult to conceive with traditional methods, drive your innovation engine with a limited financial engagement through reduced R&D costs.

    Contact us today to find out more.

  • New markets

    We create new market segments with high growth potential, thanks to our unique capabilities for non-GMO microbial strain development and discovery of novel strains from microbiomes.

    We unlock Nature’s Potential with novel microbes and natural ingredients for better living.

Technology

Disruptive technology for microbiome-based products

Droplet-based microfluidics revolutionises microbiome discovery and product development. Million-fold smaller volumes, magnitudes higher speed, and versatile assay technologies. We leave today’s limits of high-throughput automation behind.

Disruptive innovator in microbiome product development

We unlock unculturable microbiomes

No throughput limitation—culture and test millions of strains in parallel

From single cell to insight

Read more



Partnered programs

Ally with us to deliver your breakthroughs

Increase your competitiveness and profitability by product innovation. Products, formerly difficult to conceive with traditional methods, drive your innovation engine with a limited financial engagement through reduced R&D costs.

Read more

Services

Delivering results for you

Access Biomillenia’s disruptive technology platform in our services department. Our customers obtain improved R&D and product development capabilities by getting better results at higher speed and lower costs.

Directed enzyme evolution

Metabolic engineering

Strain improvement

Compound screening

Broad assay range

Read more



News

Discover latest news and information about Biomillenia. Find out about events where you can meet us.

Read more